Pentixapharm Holding AG (ETR:PTP) | WebDisclosure

Basculer en Français

10091	Companies
206582	Keywords
136756	Articles
109499	Press releases

Headlines Articles Press releases Pentixapharm Holding AG

Home
Companies
Pentixapharm Holding AG

PRESS RELEASE

published on 10/01/2024 at 18:48, 1 year 5 months ago

EQS-Adhoc: Pentixapharm Holding AG: Placement Price Set at EUR 5.10 per Share, All 3.9 Million Offer Shares Placed
Pentixapharm Holding AG sets IPO placement price at EUR 5.10 per share, placing all 3.9 million offer shares. Gross proceeds reach EUR 19.9 million. Post-money market capitalization at EUR 126.5 million

IPO Market Capitalization Pentixapharm Holding AG Placement Price Offer Shares
PRESS RELEASE

published on 09/24/2024 at 11:51, 1 year 6 months ago

Original-Research: Pentixapharm Holding AG (von BankM AG): n.a.
Pentixapharm Holding AG von BankM AG eingestuft. Präziser Theranostic-Ansatz mit validiertem Target. Potenzial in Präzisionsonkologie. Risikoadjustierte Bewertung des Eigenkapitals. Vollständige Analyse unter: http://www.more-ir.de/d/30855.pdf

BankM AG Pentixapharm Holding AG Theranostic-Ansatz Präzisionsonkologie Bewertung Eigenkapital
BRIEF

published on 09/23/2024 at 12:20, 1 year 6 months ago

Pentixapharm Holding AG fixe la fourchette de prix de son introduction en bourse

Bourse De Francfort Essais Cliniques Introduction En Bourse Produits Radiopharmaceutiques Pentixapharm
BRIEF

published on 09/23/2024 at 12:20, 1 year 6 months ago

Pentixapharm Holding AG Sets Price Range for Planned IPO

Frankfurt Stock Exchange Clinical Trials IPO Radiopharmaceuticals Pentixapharm
PRESS RELEASE

published on 09/23/2024 at 12:15, 1 year 6 months ago

Pentixapharm Holding AG Sets Price Range for Planned IPO
Pentixapharm Holding AG sets price range of EUR 4.70 to EUR 6.00 per share for planned IPO to fund product pipeline development in radioligand therapies

IPO Financial Resources Price Range Pentixapharm Holding AG Radioligand Therapies
BRIEF

published on 09/12/2024 at 15:05, 1 year 6 months ago

Pentixapharm Holding AG Plans IPO on Frankfurt Stock Exchange

Frankfurt Stock Exchange Cancer Treatment IPO Radiopharmaceuticals Phase III Trials
BRIEF

published on 09/12/2024 at 15:05, 1 year 6 months ago

Pentixapharm Holding AG envisage une introduction en bourse à Francfort

Bourse De Francfort Introduction En Bourse Traitement Du Cancer Produits Radiopharmaceutiques Essais De Phase III
PRESS RELEASE

published on 09/12/2024 at 15:00, 1 year 6 months ago

Pentixapharm Holding AG, a Subsidiary of Eckert & Ziegler SE, Plans IPO on the Prime Standard of the Frankfurt Stock Exchange
Pentixapharm Holding AG, a subsidiary of Eckert & Ziegler SE, plans IPO on the Prime Standard of the Frankfurt Stock Exchange, focusing on innovative radiopharmaceuticals for theranostics of various indications

Frankfurt Stock Exchange IPO Radiopharmaceuticals Pentixapharm Holding AG Theranostics

Accesswire

Published on 03/26/2026 at 04:55, 2 hours 58 minutes ago

Vanta Announces Capital Markets Initiatives to Strengthen Financial Position and Support Growth Initiatives
Published on 03/26/2026 at 00:40, 7 hours 13 minutes ago

Challenger RC Resource Upgrade Drilling Complete
Published on 03/26/2026 at 00:30, 7 hours 23 minutes ago

Nano One Highlights Recent Objectives & Reports Fourth Quarter 2025 Results
Published on 03/25/2026 at 19:15, 12 hours 38 minutes ago

Gemina Laboratories Ltd. Announces Delisting from the CSE
Published on 03/25/2026 at 13:30, 18 hours 23 minutes ago

Prince Silver Files NI 43-101 Technical Report for Its Stampede Gap Porphyry Copper-Gold-Molybdenum Project in Nevada

View all ACCESSWIRE

EQS Group

Published on 03/26/2026 at 07:45, 8 minutes ago

Eckert & Ziegler: Strong FY 2025 with Positive Outlook
Published on 03/26/2026 at 07:36, 17 minutes ago

Medios achieves double-digit revenue growth and improves profitability
Published on 03/26/2026 at 07:30, 23 minutes ago

Bike24 Holding AG: Accelerated growth in 2025 fueled by greater market reach, stronger results and enhanced financial stability
Published on 03/26/2026 at 07:30, 23 minutes ago

SFC Energy AG publishes annual report for 2025 – return to growth in Q4 with high profitability – wider share of defense and security applications boosting outlook for further growth in 2026
Published on 03/26/2026 at 07:30, 23 minutes ago

Scout24 SE publishes integrated annual report 2025 and proposes 14% dividend increase; guidance for 2026 reiterated

Les Echos

Published on 03/26/2026 at 07:30, 23 minutes ago

BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Published on 03/26/2026 at 07:30, 23 minutes ago

BIOPHYTIS ET LYNXKITE INVITÉS À LA CONFÉRENCE NVIDIA : L’IA AU SERVICE DE LA LONGÉVITÉ
Published on 03/25/2026 at 18:53, 12 hours 59 minutes ago

CIS - Transfert Contrat de Liquidité Portzamparc - 25.03.2026
Published on 03/25/2026 at 18:53, 13 hours ago

LNA SANTE : 2025 Annual Results
Published on 03/25/2026 at 18:31, 13 hours 22 minutes ago

Strong investment performance and active roll-out of our strategy

View all LES ECHOS COMFI WIRE